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Lon is a nuclear-encoded, mitochondrial ATP-dependent protease
that degrades oxidized damaged proteins, assists protein folding
and participates in maintaining mitochondrial DNA levels. Lon is
upregulated at the mRNA level by several stressors, including (but
not limited to) ROS, heat shock and hypoxia. However, we have
observed that in many cases changes in mRNA levels, protein levels
and activity are not directly correlated, suggesting the possibility that
Lon activity could be regulated at post transcriptional and transla-
tional level. Lysine acetylation has emerged as an important post
translational modiﬁcation used to regulate mitochondrial proteins.
While acetylation within mitochondria is basically a non enzymatic
process, lysine deacetylation is carried out by sirtuins, a class of
NAD+-dependent class III histone deacetylases. Thus, we hypothe-
sized that Lon activity could be regulated by Sirt3, the most
important mitochondrial sirtuin. We ﬁrst analysed the colocalization
of Lon and Sirt3 in mitochondria by confocal microscopy, in three
different human cell lines (MCF7, RKO, HepG2). The two proteins
colocalize, with an estimation of 70% of colocalization signal. In
hypoxic conditions, or under oxidative stress, the colocalization
signal increased to 80%, at least in RKO cells. Coimmunoprecipitation
experiments conﬁrmed a direct interaction between Lon and Sirt3,
both in basal conditions, and in the conditions of hypoxia or
oxidative stress. While silencing of Lon did not alter Sirt3 levels,
silencing of Sirt3 caused a marked increase of Lon acetylation,
suggesting that Lon is a target of Sirt3 deacetylation activity. An in
silico analysis of Lon primary sequence indicated K357, K361 and
K917 as possible acetylation targets. We focused our attention on
K917, a Lys on the surface of the catalytic domain of Lon. Protein-
protein docking analysis suggested that acetylated K917 can enter
the cavity of Sirt3 known to be involved in the deacetylation of the
Ac-ACS peptide – a substrate proved to be deacetylated by Sirt3 –
and that the same residues involved in the binding and deacetylation
of this substrate are involved in interactions with Lon. In conclusion,
Lon appeared to be a substrate of Sirt3, and its proteolytic activity
could be regulated by the acetylation status of K917.
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The cellular energy metabolism, and mitochondria in partic-
ular, is becoming a prominent target for the development of
new anticancer strategies [1]. Agents acting on mitochondria,
termed “mitocans”, include compounds that affect a variety of
mitochondrial functions [2]. Some of them are currently
undergoing clinical trials. Among the drugs under evaluation
are 2-deoxy-d-glucose, 3-bromopyruvate, etomoxir or metfor-
min. However, most of these agents are not normally very
effective when used in monotherapy and thus, their clinical use
may be restricted to combined therapies as radio- and chemo-
sensitizing drugs. Arsenic trioxide (ATO, Trisenox) is a clinically
established drug for the treatment of acute promyelocytic
leukemia [3] and also of possible interest against other
neoplastic diseases [4]. However, its efﬁcacy is frequently
limited by the requirement of high doses to effectively induce
apoptosis. We have analyzed the chemo-sensitizing efﬁcacy of
different mitocans to ATO in HL60 cells, a human acute myeloid
leukemia cell line characterized as poorly sensitive to this drug.
We show that the above-mentioned mitocans potentiate the
lethality of ATO and we analyze the biochemical basis of their
chemo-sensitizing action.
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Western diet is characterized by a high content of fats and
carbohydrates and a limited intake of plant products. Nutrient
overload (increased free fatty acids and glucose intake) leads to
metabolic disorders such as insulin resistance, type 2 diabetes and
obesity. FFAs are more than substrates for oxidative metabolism
playing a signiﬁcant role in cell signaling; they inﬂuence enzymatic
activities, gene expression, ion homeostasis, etc. Excess of fatty
acids accompanied by triglyceride accumulation in multiple tissues
including adipocytes and pancreatic beta cells results in chronic
cellular injury and dysfunction. FFAs increase mitochondrial gener-
ation of ROS by depolarization of the mitochondrial inner membrane
due to the uncoupling effect. The aim of the study was to investigate
the effect of selected free fatty acids on mitochondrial function
in murine pancreatic beta cells and human preadipocytes. As an
experimental model mouse beta cells (BTC6) line and immortal-
ized human preadipocyte cell line (Chub-S7) was selected. The
cells were incubated for 24 h with different concentration of
FFAs (PA, AA, EPA). Chub-S7 cells were incubated with lower
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